Provided by Tiger Fintech (Singapore) Pte. Ltd.

Veracyte

31.14
-0.3900-1.24%
Post-market: 31.140.00000.00%18:39 EDT
Volume:698.00K
Turnover:21.71M
Market Cap:2.43B
PE:100.45
High:31.34
Open:31.28
Low:30.77
Close:31.53
Loading ...

Should You Continue to Hold Veracyte Stock in Your Portfolio?

Zacks
·
Yesterday

Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025

Business Wire
·
Yesterday

Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term

Zacks
·
15 Apr

International Growth Drives GMED Stock Amid Fierce Competition

Zacks
·
15 Apr

Here's Why Veracyte (VCYT) is a Strong Growth Stock

Zacks
·
14 Apr

Bruker Stock May Benefit Following Its Investment in Ridom GmbH

Zacks
·
14 Apr

Veracyte And 2 More Stocks That Might Be Trading Below Their Estimated Value

Simply Wall St.
·
11 Apr

Strength Seen in Veracyte (VCYT): Can Its 13.0% Jump Turn into More Strength?

Zacks
·
10 Apr

Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago

Zacks
·
10 Apr

Veracyte Is Maintained at Buy by Guggenheim

Dow Jones
·
09 Apr

Is This the Right Time to Hold ALGN Stock in Your Portfolio?

Zacks
·
01 Apr

Is Quest Diagnostics Stock Worth Holding Onto Right Now?

Zacks
·
27 Mar

National Vision Stock Rises 28.2% YTD: Will the Rally Continue?

Zacks
·
27 Mar

Veracyte (VCYT) Up 0.7% Since Last Earnings Report: Can It Continue?

Zacks
·
26 Mar

Wall Street Analysts Believe Veracyte (VCYT) Could Rally 35.05%: Here's is How to Trade

Zacks
·
26 Mar

Is This the Right Time to Hold Integra Stock in Your Portfolio?

Zacks
·
26 Mar

Veracyte Cancer Diagnostic Platform Shows Higher Specificity Than Blood Tests

MT Newswires Live
·
26 Mar

BRIEF-New Data Demonstrate Accuracy Of Veracyte's Whole-Genome Sequencing-Based Mrd Testing Platform For Muscle-Invasive Bladder Cancer

Reuters
·
26 Mar

Veracyte Inc - to Launch First Mrd Test for Mibc in H1 2026

THOMSON REUTERS
·
26 Mar

New Data Demonstrate Accuracy of Veracyte’s Whole-Genome Sequencing-Based Mrd Testing Platform for Muscle-Invasive Bladder Cancer

THOMSON REUTERS
·
26 Mar